NM_022129.4:c.827G>A

Variant summary

Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PM2PP3_Strong

The NM_022129.4(PBLD):​c.827G>A​(p.Gly276Glu) variant causes a missense change. The variant allele was found at a frequency of 0.000000684 in 1,461,838 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G276A) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 6.8e-7 ( 0 hom. )

Consequence

PBLD
NM_022129.4 missense

Scores

11
6
2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 5.15

Publications

0 publications found
Variant links:
Genes affected
PBLD (HGNC:23301): (phenazine biosynthesis like protein domain containing) Enables identical protein binding activity. Involved in maintenance of gastrointestinal epithelium; negative regulation of SMAD protein signal transduction; and negative regulation of transforming growth factor beta receptor signaling pathway. Located in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_pathogenic. The variant received 6 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.991

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PBLDNM_022129.4 linkc.827G>A p.Gly276Glu missense_variant Exon 10 of 10 ENST00000358769.7 NP_071412.2 P30039-1A0A024QZK5
PBLDXM_005270028.5 linkc.827G>A p.Gly276Glu missense_variant Exon 10 of 10 XP_005270085.1 P30039-1A0A024QZK5
PBLDXM_011540060.4 linkc.802G>A p.Glu268Lys missense_variant Exon 10 of 10 XP_011538362.1
PBLDXM_017016513.2 linkc.802G>A p.Glu268Lys missense_variant Exon 10 of 10 XP_016872002.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PBLDENST00000358769.7 linkc.827G>A p.Gly276Glu missense_variant Exon 10 of 10 5 NM_022129.4 ENSP00000351619.2 P30039-1
PBLDENST00000309049.8 linkc.827G>A p.Gly276Glu missense_variant Exon 10 of 10 1 ENSP00000308466.4 P30039-1
PBLDENST00000336578.5 linkc.728G>A p.Gly243Glu missense_variant Exon 8 of 8 1 ENSP00000338041.1 A0A0C4DFS0
PBLDENST00000468798.5 linkc.212-927G>A intron_variant Intron 2 of 2 3 ENSP00000476261.1 V9GY00

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
6.84e-7
AC:
1
AN:
1461838
Hom.:
0
Cov.:
31
AF XY:
0.00000138
AC XY:
1
AN XY:
727220
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33478
American (AMR)
AF:
0.00
AC:
0
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53414
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
8.99e-7
AC:
1
AN:
1111980
Other (OTH)
AF:
0.00
AC:
0
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Mar 10, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.827G>A (p.G276E) alteration is located in exon 10 (coding exon 9) of the PBLD gene. This alteration results from a G to A substitution at nucleotide position 827, causing the glycine (G) at amino acid position 276 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.95
BayesDel_addAF
Pathogenic
0.42
D
BayesDel_noAF
Pathogenic
0.36
CADD
Uncertain
25
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.50
D;T;T
Eigen
Pathogenic
0.74
Eigen_PC
Uncertain
0.55
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Uncertain
0.91
D;D;.
M_CAP
Uncertain
0.19
D
MetaRNN
Pathogenic
0.99
D;D;D
MetaSVM
Pathogenic
0.94
D
MutationAssessor
Pathogenic
4.9
.;H;H
PhyloP100
5.2
PrimateAI
Benign
0.48
T
PROVEAN
Pathogenic
-7.7
D;D;D
REVEL
Pathogenic
0.71
Sift
Pathogenic
0.0
D;D;D
Sift4G
Pathogenic
0.0
D;D;D
Polyphen
1.0
.;D;D
Vest4
0.83
MutPred
0.96
.;Loss of methylation at R275 (P = 0.0376);Loss of methylation at R275 (P = 0.0376);
MVP
0.91
MPC
0.79
ClinPred
1.0
D
GERP RS
5.9
Varity_R
0.94
gMVP
0.92
Mutation Taster
=65/35
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.13
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2044259494; hg19: chr10-70043974; API